Advanced Therapy Medicinal Products in type I diabetes mellitus: technological and regulatory challenges
Introduction: Type 1 Diabetes mellitus (T1DM) is an autoimmune disorder which arises from the destruction of insulin-producing pancreatic β-cells. Currently, Brazil’s advanced therapy medicinal products (ATMP), developed for clinical research and therapeutic purposes, take place in the so-called Cel...
Sparad:
| I publikationen: | Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia |
|---|---|
| Huvudupphov: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Fundação Oswaldo Cruz
2018
|
| Ämnen: | |
| Länkar: | https://www.redalyc.org/articulo.oa?id=570563069006 https://www.redalyc.org/journal/5705/570563069006/ https://www.redalyc.org/journal/5705/570563069006/html/ https://www.redalyc.org/journal/5705/570563069006/570563069006.epub https://www.redalyc.org/journal/5705/570563069006/movil |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
